U.S., May 23 -- ClinicalTrials.gov registry received information related to the study (NCT06985693) titled 'Medipixel XA-Assisted PCI in Coronary Artery Disease' on May 15.
Brief Summary: This prospective, multicenter, single-arm, interventional study evaluates the effectiveness and safety of Medipixel XA-Assisted Percutaneous Coronary Intervention (MPXA-PCI) in patients with coronary artery disease (CAD). The study aims to assess procedural success rates and clinical outcomes associated with the novel MPXA-assisted PCI strategy in a real-world clinical setting.
A total of 830 patients with de novo coronary lesions eligible for drug-eluting stent (DES) implantation will be enrolled. All participants will undergo MPXA-assisted lesion asses...